07/25/2024 8:38 PM | IO Biotech (Subject) Novo Holdings A/S (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/11/2024 3:44 PM | IO Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/07/2024 3:12 PM | Collins Helen Louise (Reporting) IO Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 3:16 PM | Glaub Kathleen Sereda (Reporting) IO Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 3:17 PM | Hirth Peter (Reporting) IO Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 3:18 PM | Hunter Heidi (Reporting) IO Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 3:19 PM | IO Biotech (Issuer) Smith David V (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
05/14/2024 8:35 PM | IO Biotech (Subject) Novo Holdings A/S (Filed by)
| Form SC 13G/A | |
05/14/2024 8:13 PM | IO Biotech (Issuer) Novo Holdings A/S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/14/2024 7:30 AM | IO Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/14/2024 7:13 AM | IO Biotech (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/10/2024 8:02 PM | IO Biotech (Subject) Novo Holdings A/S (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/26/2024 4:26 PM | IO Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/24/2024 3:05 PM | IO Biotech (Filer)
| Form DEF 14A | |
04/24/2024 3:06 PM | IO Biotech (Filer)
| Form DEFA14A | |
04/24/2024 3:07 PM | IO Biotech (Filer)
| Form ARS | |
03/22/2024 4:06 PM | IO Biotech (Filer)
| Form 10-K/A | |
03/18/2024 3:24 PM | IO Biotech (Issuer) Sullivan Amy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/18/2024 3:27 PM | IO Biotech (Issuer) Zocca Mai-Britt (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 3:56 PM | IO Biotech (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/05/2024 4:17 PM | IO Biotech (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/13/2024 8:31 PM | IO Biotech (Issuer) Novo Holdings A/S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 8:34 PM | IO Biotech (Subject) Novo Holdings A/S (Filed by)
| Form SC 13D/A | |
02/13/2024 6:38 PM | BANK OF AMERICA CORP /DE/ (Filed by) IO Biotech (Subject)
| Form SC 13G/A | |
02/09/2024 8:31 PM | IO Biotech (Subject) Novo Holdings A/S (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024 7:11 AM | IO Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/18/2023 4:14 PM | IO Biotech (Subject) Samsara BioCapital, L.P. (Filed by)
| Form SC 13G | |
11/24/2023 4:37 PM | Burkavage Brian (Reporting) IO Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/17/2023 3:47 PM | Collins Helen Louise (Reporting) IO Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/17/2023 3:41 PM | Collins Helen Louise (Reporting) IO Biotech (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
11/13/2023 7:10 AM | IO Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/12/2023 3:06 PM | IO Biotech (Filer)
| Form 424B2 Transaction specifc information for a delayed shelf offering | |
09/10/2023 11:15 PM | IO Biotech (Filer)
| Form EFFECT | |
09/07/2023 9:36 AM | IO Biotech (Subject) Kurma Partners (Filed by)
| Form SC 13G | |
08/30/2023 3:16 PM | IO Biotech (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
08/21/2023 2:40 PM | IO Biotech (Issuer) Kurma Partners (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
08/16/2023 3:15 PM | IO Biotech (Subject) Stonepine Capital Management, LLC (Filed by)
| Form SC 13G | |
08/15/2023 5:02 PM | Hunter Heidi (Reporting) IO Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2023 4:57 PM | Hunter Heidi (Reporting) IO Biotech (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
08/15/2023 2:15 PM | HBM Healthcare Investments Ltd. (0001232258) (Filed by) IO Biotech (Subject)
| Form SC 13G/A | |
08/14/2023 2:45 PM | IO Biotech (Subject) Lundbeckfond Invest A/S (Filed by)
| Form SC 13D/A | |
Automatic Income (from home) (Ad) Everyone’s talking about this new income hack that could generate triple digit returns on your money.
But here’s the best part…![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=8620&Placement=NativeDisplay&Source=NativeDisplay) Watch this short video |
08/14/2023 2:45 PM | HBM Healthcare Investments Ltd. (0001232258) (Filed by) IO Biotech (Subject)
| Form SC 13G/A | |
08/11/2023 8:22 PM | IO Biotech (Issuer) Lundbeckfond Invest A/S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/11/2023 8:24 PM | Elling Christian E (Reporting) IO Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/11/2023 7:41 AM | IO Biotech (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/11/2023 7:31 AM | IO Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/10/2023 8:03 AM | IO Biotech (Issuer) Vivo Capital Fund IX, L.P. (Reporting) Vivo Capital IX, LLC (Reporting) Vivo Opportunity Fund Holdings, L.P. (Reporting) Vivo Opportunity, LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/09/2023 7:43 PM | IO Biotech (Issuer) Zocca Mai-Britt (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/09/2023 7:38 PM | IO Biotech (Issuer) Smith Devin Whittemore (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/09/2023 7:41 PM | IO Biotech (Issuer) Sullivan Amy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2023 7:31 AM | IO Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |